BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported third-quarter net income of $1.08 billion.
On a per-share basis, the Boston-based company said it had profit of $4.20. Earnings, adjusted for one-time gains and costs, were $4.80 per share.
The results exceeded Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment Research was for earnings of $4.55 per share.
The drugmaker posted revenue of $3.08 billion in the period, also beating Street forecasts. Eleven analysts surveyed by Zacks expected $3.04 billion.
Vertex expects full-year revenue in the range of $11.9 billion to $12 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VRTX at https://www.zacks.com/ap/VRTX
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
